Cargando…
PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430055/ http://dx.doi.org/10.1097/01.HS9.0000974284.84633.60 |
| _version_ | 1785090862128037888 |
|---|---|
| author | Naka, Ryosuke Kondo, Tadakazu Nishikubo, Masashi Muranushi, Hiroyuki Ueda, Yasunori Oka, Tomomi Wada, Fumiya Kanda, Junya Yamamoto, Shohei Watanabe, Mitsumasa Okada, Shinri Imada, Kazunori Nakabo, Yukiharu Mizutani, Yu Nannya, Yasuhito Ogawa, Seishi Ishikawa, Takayuki |
| author_facet | Naka, Ryosuke Kondo, Tadakazu Nishikubo, Masashi Muranushi, Hiroyuki Ueda, Yasunori Oka, Tomomi Wada, Fumiya Kanda, Junya Yamamoto, Shohei Watanabe, Mitsumasa Okada, Shinri Imada, Kazunori Nakabo, Yukiharu Mizutani, Yu Nannya, Yasuhito Ogawa, Seishi Ishikawa, Takayuki |
| author_sort | Naka, Ryosuke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104300552023-08-17 PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT Naka, Ryosuke Kondo, Tadakazu Nishikubo, Masashi Muranushi, Hiroyuki Ueda, Yasunori Oka, Tomomi Wada, Fumiya Kanda, Junya Yamamoto, Shohei Watanabe, Mitsumasa Okada, Shinri Imada, Kazunori Nakabo, Yukiharu Mizutani, Yu Nannya, Yasuhito Ogawa, Seishi Ishikawa, Takayuki Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430055/ http://dx.doi.org/10.1097/01.HS9.0000974284.84633.60 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Naka, Ryosuke Kondo, Tadakazu Nishikubo, Masashi Muranushi, Hiroyuki Ueda, Yasunori Oka, Tomomi Wada, Fumiya Kanda, Junya Yamamoto, Shohei Watanabe, Mitsumasa Okada, Shinri Imada, Kazunori Nakabo, Yukiharu Mizutani, Yu Nannya, Yasuhito Ogawa, Seishi Ishikawa, Takayuki PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title | PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title_full | PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title_fullStr | PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title_full_unstemmed | PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title_short | PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT |
| title_sort | pb1862: venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430055/ http://dx.doi.org/10.1097/01.HS9.0000974284.84633.60 |
| work_keys_str_mv | AT nakaryosuke pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT kondotadakazu pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT nishikubomasashi pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT muranushihiroyuki pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT uedayasunori pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT okatomomi pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT wadafumiya pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT kandajunya pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT yamamotoshohei pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT watanabemitsumasa pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT okadashinri pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT imadakazunori pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT nakaboyukiharu pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT mizutaniyu pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT nannyayasuhito pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT ogawaseishi pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment AT ishikawatakayuki pb1862venetoclaxandazacitidinetherapyinacutemyeloidleukemiapatientswithsevererenalimpairment |